WALTHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with ...

Quantbot Technologies LP acquired a new position in shares of Dyne Therapeutics in the 3rd quarter valued at $34,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ...